Press
Releases
GfK
U.S. Healthcare Companies Announces Executive and Senior Leadership Appointments
New President
Named at GfK Strategic Marketing; Senior Vice Presidents Join GfK Market
Measures and GfK V2
BLUE BELL, PA, April 5, 2007 — The GfK U.S. Healthcare
Companies, the largest custom healthcare marketing research provider in
the United States, recently announced the following leadership appointments
for its family of companies consisting of GfK Strategic Marketing, GfK
Market Measures, and GfK V2.
GfK Strategic Marketing named Brian Hull, M.B.A.,
company President following the departure of Marty Glogowski, who last
month announced his retirement.
Hull
has worked in all aspects of global primary marketing research in the
pharmaceutical industry. He spent the last five years working at GfK V2
as an Executive Vice President, where he successfully grew and led a strategic
business unit. Prior to working at GfK V2, Hull spent the early part of
his career at Migliara/Kaplan Associates where he became a Senior Vice
President and led multiple strategic business units. He also played a
critical role in the successful development of a start-up Internet primary
marketing research firm, where he was responsible for business development
and led the creation of a new Internet sales force and message effectiveness
methodology. Hull holds a Masters in Business Administration from Indiana
University.
GfK Market Measures appointed Bill Bowman, J.D.,
as Vice President of Oncology and Jenny Donohue, Ph.D.,
as Senior Vice President, Multi-Client.
As
Vice President of Oncology, Bowman leads a dedicated
business unit that will support the company’s strategic efforts
in this rapidly growing area of research. In his new role, Bowman, who
has more than 15 years of oncology experience, is responsible for developing
syndicated products for oncology and serves as a key in-house resource
for custom marketing research studies involving cancer therapies.
In his 25-year career in the pharmaceutical industry, Bowman has been
a marketing researcher, product manager and sales representative with
several major pharmaceutical manufacturers and supply-side firms.
Prior to joining GfK Market Measures, Bowman most recently served as an
independent marketing research consultant working in partnership with
oncology product teams for several of the industry’s most successful
cancer therapies.
Dr.
Donohue has more than 25 years of experience in conducting marketing,
economic, quality of life and health policy research for pharmaceutical
and biotechnology companies, government and research institutions. Over
the last 10 years, she has founded, grown and successfully sold two companies:
Competency Assessment Solutions, LLC, a software and services company
that provides Web-based performance appraisal and learning management
solutions to health care institutions, and Consumer Health Sciences, the
“gold standard” in patient reported health care information
products and services for the pharmaceutical industry in the United States
and Europe. Earlier in her career, Dr. Donohue worked on the client side
of the business, holding senior level marketing research and branding
positions at Johnson & Johnson and Merck & Co. She holds a Ph.D.
in Social Research from Bryn Mawr College.
GfK V2 named Andrea Alfonsi, M.B.A.,
Steve Finestone, M.B.A., and Howard Jaffe, M.S.,
as Senior Vice President and Strategic Business Unit Heads.
Alfonsi’s
primary research focus is in the biotech and specialty pharmaceutical
sector. She is well-versed in a variety of techniques ranging from exploratory
qualitative to highly complex quantitative methodologies and is known
for her expertise in using research to build and evaluate successful brand
strategies in areas such as market assessments, new and supplemental indications,
positioning, competitive activity, segmentation and messaging. Prior to
joining GfK V2, Alfonsi led a team of client service and research professionals
at Ziment, where she spent the last nine years. She holds an M.B.A. with
a Marketing concentration from Drexel University.
For
the last 10 years, Finestone has worked with a variety
of pharmaceutical and biotech firms as President of SZF Associates, Inc.,
his own healthcare marketing research and consulting firm which specialized
in new product research and promotional analysis. Prior to founding SZF
Associates, Finestone spent eight years on the client side of the business
as a Market Research/Business Planning Analyst, Manager and Director at
Wyeth specializing in areas such as new products, women’s health,
cardiovasculars, CNS, pain and arthritis and pediatrics. He holds an M.B.A.
in Marketing and Finance from Cornell University.
Jaffe
brings unique insights to marketing research projects by incorporating
his career experiences in areas such as pharmaceutical sales, advertising
and marketing.
As a quantitative researcher, he has developed new approaches to understanding
treatment algorithms, identifying and measuring brand opportunities and
patient archetypes. He is also experienced in qualitative methodologies
with an emphasis on early product development, branding, positioning and
advertising research. Most recently, Jaffe worked as Vice President/Account
Executive at The Mattson Jack Group and also held a similar role at TNS
Healthcare. Prior to these positions, he served as Vice President and
Head of U.S. Operations for Genactics, Inc. Jaffe holds a Master’s
degree in Biology from Villanova University.
About GfK U.S. Healthcare Companies
The GfK U.S. Healthcare Companies - comprised of GfK Market Measures,
GfK Strategic Marketing, and GfK V2 - is the largest custom healthcare
marketing research provider in the United States. Collectively, the GfK
U.S. Healthcare Companies have more than 250 employees and service virtually
all of the pharmaceutical and healthcare manufacturing companies in the
United States, as well as many of the largest manufacturers abroad. As
a member of the GfK Group (GfK = Growth from Knowledge), based in Nuremberg,
Germany, the GfK U.S. Healthcare Companies are part of the fourth largest
marketing research provider in the world. For further information please
visit www.gfkushc.com.
|